We are live on
!
Find out more
Natixis Advisors Portfolio holdings
AUM
$71.9B
1-Year Est. Return
28.03%
This Fund
S&P 500
This Quarter
Est. Return
+23.14%
1 Year Est. Return
+28.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+131.42%
10 Year Est. Return
+475.22%
AUM
$15.1B
AUM Growth
+$2.8B
(+23%)
Cap. Flow
+$270M
Cap. Flow
% of AUM
1.79%
Top 10 Holdings %
Top 10 Hldgs %
16.95%
Holding
1,214
New
61
Increased
628
Reduced
457
Closed
64
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE Value ETF
EFV
|
+$153M |
| 2 |
Boeing
BA
|
+$65.2M |
| 3 |
Salesforce
CRM
|
+$39.5M |
| 4 |
UnitedHealth
UNH
|
+$26.5M |
| 5 |
Vanguard Total Bond Market
BND
|
+$25.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Value ETF
VTV
|
+$127M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$126M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$63.9M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$53.5M |
| 5 |
Vanguard Mid-Cap Value ETF
VOE
|
+$51.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.02% |
| 2 | Healthcare | 13.82% |
| 3 | Financials | 13.1% |
| 4 | Consumer Discretionary | 9.88% |
| 5 | Industrials | 9.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Monster Beverage
MNST
$91.4B
| $95.8M | 0.64% |
2,762,568
+22,470
| +0.8% | +$734K |
|
27
Thermo Fisher Scientific
TMO
$211B
| $94.6M | 0.63% |
261,113
+29,478
| +13% | +$9.88M |
|
28
Deere & Co
DE
$170B
| $86.6M | 0.58% |
551,288
+134,355
| +32% | +$19.5M |
|
29
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.2B
| $83.2M | 0.55% |
861,360
+118,962
| +16% | +$10.6M |
|
|
30
Vanguard Mid-Cap Value ETF
VOE
$23.7B
| $82M | 0.54% |
857,146
-565,634
| -40% | -$51.9M |
|
31
Verizon
VZ
$194B
| $81.3M | 0.54% |
1,474,182
+181,502
| +14% | +$10.2M |
|
32
Walt Disney
DIS
$165B
| $78.3M | 0.52% |
702,175
+154,632
| +28% | +$17.1M |
|
33
Union Pacific
UNP
$183B
| $77.2M | 0.51% |
456,825
+78,685
| +21% | +$12.6M |
|
34
TSMC
TSM
$2.09T
| $74.9M | 0.5% |
1,318,830
+191,630
| +17% | +$10.1M |
|
35
Mastercard
MA
$477B
| $74.5M | 0.49% |
251,924
+35,182
| +16% | +$9.92M |
|
36
Medtronic
MDT
$107B
| $72.3M | 0.48% |
788,030
+17,931
| +2% | +$1.72M |
|
37
Texas Instruments
TXN
$255B
| $70.6M | 0.47% |
556,134
+97,057
| +21% | +$11.3M |
|
|
NVO
38
Novo Nordisk
NVO
$216B
| $70.3M | 0.47% |
2,147,994
-879,250
| -29% | -$28.1M |
|
39
Expeditors International
EXPD
$22.9B
| $69M | 0.46% |
907,831
+13,266
| +1% | +$969K |
|
40
Citigroup
C
$222B
| $68.6M | 0.46% |
1,343,012
+63,165
| +5% | +$3M |
|
41
Adobe
ADBE
$89.5B
| $67.9M | 0.45% |
156,086
+11,482
| +8% | +$4.25M |
|
42
Starbucks
SBUX
$118B
| $65.6M | 0.44% |
891,713
+27,868
| +3% | +$2.09M |
|
43
Procter & Gamble
PG
$343B
| $63.6M | 0.42% |
531,957
-250,631
| -32% | -$29.2M |
|
44
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.5B
| $63.1M | 0.42% |
1,177,595
-437,656
| -27% | -$22.1M |
|
45
Intel
INTC
$466B
| $63M | 0.42% |
1,053,314
+160,840
| +18% | +$9.62M |
|
46
Roper Technologies
ROP
$36.3B
| $62.2M | 0.41% |
160,235
+43,194
| +37% | +$15.5M |
|
47
Abbott
ABT
$180B
| $62M | 0.41% |
677,777
+125,952
| +23% | +$11.4M |
|
48
Vanguard Small-Cap Growth ETF
VBK
$23.2B
| $61.4M | 0.41% |
307,758
-111,475
| -27% | -$20.1M |
|
49
PayPal
PYPL
$49.5B
| $61.1M | 0.41% |
350,407
+21,596
| +7% | +$2.98M |
|
50
AbbVie
ABBV
$458B
| $60.7M | 0.4% |
618,208
+54,980
| +10% | +$4.84M |
|
Similar funds
Natixis Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, Natixis Advisors held 1,214 positions worth $15.1B, up 23% from $12.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Natixis Advisors's Q2 2020 filing shows 61 new, 628 increased, 457 reduced and 64 closed positions. Its largest new stake was Markel Group: 10,289 shares worth $9.5M. The largest sale was Vanguard Value ETF, an estimated $127M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- Natixis Advisors's largest Q2 2020 buy was Markel Group: 10,289 shares worth $9.5M.
- Natixis Advisors added most to iShares MSCI EAFE Value ETF in Q2 2020, an estimated $153M increase.
- Natixis Advisors's biggest Q2 2020 reduction was Vanguard Value ETF, cutting an estimated $127M.
- Natixis Advisors fully exited Allergan plc in Q2 2020, selling an estimated $21.5M.
- Natixis Advisors's ten largest holdings make up 17% of its $15.1B portfolio in Q2 2020.
- Natixis Advisors opened 61 new positions and closed 64 in Q2 2020.
- Natixis Advisors's portfolio value rose 23% quarter-over-quarter to $15.1B.
Based on Natixis Advisors's 13F filing for Q2 2020, filed 11 Aug 2020.